glp 1 agonist weight loss GLP-1 medications for Glucagon-like peptide-1 receptor agonists and

The recently initiated large-sized FLOW trial investigating the effects of semaglutide on hard renal outcomes in patients with DKD will provide clarity whether GLP-1 receptor agonists may reduce the burden of DKD in addition to their other beneficial metabolic and cardiovascular effects.

They stimulate insulin secretion and inhibit glucagon secretion by elevating e...

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

Aspiration of gastric contents can still occur despite appropriate preoperative fasting in patients taking GLP-1 agonists

Heads of State adopted a new Political Declaration under the 2030 Agenda for Sustainable Development - to reduce premature NCD mortality by one-third by 2030